Lawson D H, Stockton L H, Bleier J C, Acosta P B, Heymsfield S B, Nixon D W
Am J Clin Nutr. 1985 Jan;41(1):73-84. doi: 10.1093/ajcn/41.1.73.
Previous studies indicate dietary phenylalanine and tyrosine restriction may be of value in managing advanced cancer patients. To further evaluate this approach, we performed a 60-day study in which four patients with advanced malignant melanoma received formula diets via nasogastric tube containing only 8 mg total phenylalanine and tyrosine per kg lean body mass per day. Two of three patients completing elemental balance studies were in negative nitrogen, potassium, and phosphorus balance, suggesting an essential nutrient deficiency. Three patients tolerated the diet well, but one was non-compliant. Although no serious toxicity developed, serum albumin, total iron binding capacity and cholesterol significantly decreased (p less than 0.01) in the three complaint patients. Fasting plasma phenylalanine and tyrosine values did not significantly change during the study, but two-hour postprandial plasma phenylalanine and tyrosine concentrations fell below normal and were significantly lower than preprandial levels (p less than 0.01). There were no tumor responses.
先前的研究表明,限制饮食中的苯丙氨酸和酪氨酸可能对晚期癌症患者的治疗有价值。为了进一步评估这种方法,我们进行了一项为期60天的研究,4例晚期恶性黑色素瘤患者通过鼻胃管接受配方饮食,每天每千克瘦体重仅含8毫克苯丙氨酸和酪氨酸。完成元素平衡研究的3例患者中有2例处于负氮、钾和磷平衡状态,提示存在必需营养素缺乏。3例患者对饮食耐受性良好,但1例不依从。尽管未出现严重毒性反应,但3例依从患者的血清白蛋白、总铁结合力和胆固醇显著降低(p<0.01)。研究期间空腹血浆苯丙氨酸和酪氨酸值无显著变化,但餐后2小时血浆苯丙氨酸和酪氨酸浓度低于正常水平,且显著低于餐前水平(p<0.01)。未观察到肿瘤反应。